Catalyst
Slingshot members are tracking this event:
Aerie (AERI) Expects ROCKET 4 Safety Data in Q4 2016 Analyzing Rhopressa in Lowering Intraocular Pressure (IOP) in Patients with Glaucoma or Ocular Hypertension
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
AERI |
|
|
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 27, 2016
Occurred Source:
http://investors.aeriepharma.com/releasedetail.cfm?ReleaseID=995966
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Rocket 4 Safety Data, Rhopressa, Lowering Intraocular Pressure, Glaucoma, Ocular Hypertension